SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-048495
Filing Date
2020-10-29
Accepted
2020-10-29 06:11:59
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20200930.htm   iXBRL 10-Q 2937774
2 EX-31.1 cnst-ex311_10.htm EX-31.1 9609
3 EX-31.2 cnst-ex312_7.htm EX-31.2 9580
4 EX-32.1 cnst-ex321_6.htm EX-32.1 5679
5 EX-32.2 cnst-ex322_8.htm EX-32.2 5759
  Complete submission text file 0001564590-20-048495.txt   8714105

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cnst-20200930.xsd EX-101.SCH 43827
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20200930_cal.xml EX-101.CAL 41530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20200930_def.xml EX-101.DEF 132746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20200930_lab.xml EX-101.LAB 342427
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20200930_pre.xml EX-101.PRE 265347
11 EXTRACTED XBRL INSTANCE DOCUMENT cnst-10q_20200930_htm.xml XML 1699907
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 201270361
SIC: 2834 Pharmaceutical Preparations